Abstract
Orphan drugs are medicinal products use for therapy of rare serious diseases (with prevalence 50/1000). European union legislation for orphan drugs designation is described, and the list of orphan drugs used in CR is added.
Orphan drugs are medicinal products use for therapy of rare serious diseases (with prevalence 50/1000). European union legislation for orphan drugs designation is described, and the list of orphan drugs used in CR is added.